The weekly litigation news digest is live. Subscribe now

IP Verse

Glaxosmithkline vs. Biontech - ACT_32214/2025

The case ACT_32214/2025 was filed by the plaintiff Glaxosmithkline Biologicals against the defendant Biontech, CP Pharmaceuticals CV, Laboratorios Pfizer on 03 Jul, 2025.

Case Timeline

03 Jul, 2025
Case Filed
Today Nov 21, 2025
Decision

Case Details

    Case Number:

    ACT_32214/2025

    Patent Number:

    EP2590626

    Filing Date:

    03 Jul, 2025

    Proceeding Type:

    Proceeding

    Action/Application:

    Infringement Action

    Plaintiffs:

    • Glaxosmithkline Biologicals
    • Glaxosmithkline Biologicals Sa

    Plaintiff Representative:

    • Carlos VAN STAVEREN

    Defendants:

    • Biontech
    • Biontech Europe
    • Biontech Europe Gmbh
    • Biontech Manufacturing
    • Biontech Manufacturing Gmbh
    • Biontech Manufacturing Marburg
    • Biontech Manufacturing Marburg Gmbh
    • Biontech Se
    • CP Pharmaceuticals CV
    • Laboratorios Pfizer
    • Pfizer
    • Pfizer AB
    • Pfizer Austria Gesellschaft
    • Pfizer Croatia DOO
    • Pfizer Export
    • Pfizer Gyogyszerkereskedelmi KFT
    • Pfizer Hellas AE
    • Pfizer Inc.
    • Pfizer Luxembourg
    • Pfizer Luxembourg S.A.R.L.
    • Pfizer Manufacturing Belgium
    • Pfizer Manufacturing Belgium Nv
    • Pfizer Pharma
    • Pfizer Pharma Gmbh
    • Pfizer Polska SP ZOO
    • Pfizer Romania
    • Pfizer Sanv
    • Pfizer Service Bvsrl
    • Pfizer Trading Polska SP ZOO

    Defendant Representative:

    • Christian Dekoninck
    • Tessa Waldron

    Judges:

    • Edger Brinkman
    • Margot Kokke
    • Stefan Schilling

    Court Division:

    First Instance, Local Division - The Hague

Case Decision

Decision pending - set alert to receive updates

More cases involving EP2590626B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Nov 20, 2025
Case NumberFiling DatePlaintiffsDefendants
UPC_CFI_616/2025Nov 6, 2025GlaxosmithklineModerna
ACT_32120/2025Jul 3, 2025GlaxosmithklineModerna
UPC_CFI_620/2025Jul 3, 2025GlaxosmithklineBiontech, Biontech Europe, Biontech Manufacturing, Biontech Manufacturing Marburg, CP Pharmaceuticals CV, Pfizer

More cases involving Glaxosmithkline

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Nov 20, 2025
Case NumberFiling DatePlaintiffsDefendants
UPC_CFI_616/2025Nov 6, 2025GlaxosmithklineModerna
APP_33242/2025Jul 21, 2025Glaxosmithkline -
APP_33256/2025Jul 21, 2025Glaxosmithkline -

More cases involving Biontech

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Nov 20, 2025
Case NumberFiling DatePlaintiffsDefendants
ACT_32285/2025Jul 3, 2025GlaxosmithklineBiontech, Biontech Europe, Biontech Manufacturing, Biontech Manufacturing Marburg
APP_29246/2025Jul 3, 2025Biontech, Biontech Europe, Biontech Innovative Manufacturing Services, Biontech Manufacturing, Biontech Manufacturing Marburg -
UPC_CFI_620/2025Jul 3, 2025GlaxosmithklineBiontech, Biontech Europe, Biontech Manufacturing, Biontech Manufacturing Marburg